ME STOCK NOTICE: An Investigation has been Initiated Against 23andMe Holding Co. for Breaches of Fiduciary Duties – Shareholders are Urged to Contact BFA LawAccesswire • Thursday
Wolf Popper LLP is Investigating Whether the Offer to Acquire 23andMe Holding Co. By Its Controlling Shareholder Is Fair to the Minority ShareholdersGlobeNewsWire • Thursday
ME STOCK ALERT: 23andMe Holding Co. Shareholders are Notified that an Investigation has been Initiated Against the Company's Board of Directors and are Urged to Contact BFA Law (NASDAQ:ME)GlobeNewsWire • Thursday
23andMe board resigns in feud over CEO Anne Wojcicki's plan to take company privateNew York Post • Wednesday
23andMe's stock tumbles 7% after independent directors quit in clash with CEO over buyout planMarket Watch • Wednesday
23andMe CEO Anne Wojcicki 'surprised and disappointed' by board resignations: Read the memoCNBC • Wednesday
23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 TrialGlobeNewsWire • 09/15/24
23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 StudyGlobeNewsWire • 09/15/24
One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All PopulationsGlobeNewsWire • 09/12/24
23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024GlobeNewsWire • 09/03/24
Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership ProgramGlobeNewsWire • 08/28/24
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data BreachAccesswire • 08/12/24